Gangwal Chemicals, located in Mumbai India, is a high-end distributor and specialty solutions provider having a leading position in pharmaceuticals with a focus on specialty excipients. The company is growing significantly in the distribution of specialty ingredients in nutraceutical and cosmetics ingredients.

The acquisition is an important step in Barentz’ strategy to become a leading global specialty pharmaceutical and nutraceutical active ingredient distributor. The acquisition is, however, subject to customary closing conditions.

The intended acquisition strengthens Barentz’ footprint in the high growth and resilient pharma excipient distribution market and increases geographic exposure in the fast-growing Asia-Pacific region

Anil Jain, the founder of Gangwal, will continue to lead the company post completion of the acquisition by Barentz

“We have been keen to enter the Indian market for a long time,” said Hidde van der Wal, CEO of Barentz. “In Gangwal, we found the right partner due to the similarities in how we do business. We are extremely impressed by the way the Gangwal team has developed the business and the long-term relationships they have built with different global excipient producers. This platform gives us a great leadership team and many opportunities to create new business initiatives to support our global network of suppliers.  We are looking forward to accelerating Gangwal’s future strategic growth.”

“Over the last couple of years we have seen a rapid consolidation of distributors in India,” Jain, promoter and director of Gangwal Chemicals, added. “In Barentz, we found the ideal life science candidate to partner with. DNA- and business wise we think and act alike. Together, we can find multiple synergies to strengthen our customer relations with many new suppliers and products coming out of the Barentz portfolio of life science ingredients.”